Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC482

Iptacopan eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    30.9.2024
  • Application published:
    15.9.2025
  • Grant published:
    15.9.2025
  • Max expiry date:
    20.5.2039
  • Medicine name:
    Fabhalta
  • Medicine for children:
    No

Timeline

Today
30.9.2024Application
15.9.2025Publication
15.9.2025Registration
20.5.2039Expires

Marketing license

  • IS authorization number:
    EU1/24/1802
  • Date:
    25.6.2024
  • Foreign authorization number:
    EU/1/24/1802
  • Date:
    17.5.2024

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents